Filing Flows › Comparisons › ADCT vs NAMS
ADC Therapeutics SA vs NewAmsterdam Pharma Co N.V.: ADCT and NAMS compared
ADC Therapeutics SA is the larger company: $19.2M of revenue in its latest quarter (Q2 2026) against $19.2M for NewAmsterdam Pharma Co N.V. (Q3 2026). NewAmsterdam Pharma Co N.V. is growing faster (55× against +2% a year earlier). ADC Therapeutics SA is more profitable, with an operating margin of -132.0% against -230.6%.
Where the money goes: ADCT and NAMS
ADC Therapeutics SA (ADCT) · Q2 2026
ADC Therapeutics SA, Q2 2026: revenue $19.2M (+2% year over year), operating margin -132.0%, net loss $16.6M, operating cash flow −$11.8M. The chart follows the revenue to costs, profit and cash.
NewAmsterdam Pharma Co N.V. (NAMS) · Q3 2026
NewAmsterdam Pharma Co N.V., Q3 2026: revenue $19.2M (55× year over year), operating margin -230.6%, net loss $17.4M, operating cash flow −$39.8M. The chart follows the revenue to costs, profit and cash.
| ADC Therapeutics SA (ADCT) | NewAmsterdam Pharma Co N.V. (NAMS) | |
|---|---|---|
| Latest quarter | Q2 2026 | Q3 2026 |
| Revenue | $19.2M | $19.2M |
| Revenue growth, Y/Y | +2% | 55× |
| Operating margin | -132.0% | -230.6% |
| Net earnings | −$16.6M | −$17.4M |
| Net margin | -86.1% | -90.7% |
| Operating cash flow | −$11.8M | −$39.8M |
Where the revenue comes from
ADC Therapeutics SA
- Product revenues, net: $18.6M (97%)
- Royalties: $614K (3%)
Questions
Which is bigger, ADC Therapeutics SA or NewAmsterdam Pharma Co N.V.?
ADC Therapeutics SA is the larger company: $19.2M of revenue in its latest quarter (Q2 2026) against $19.2M for NewAmsterdam Pharma Co N.V. (Q3 2026).
Is ADC Therapeutics SA or NewAmsterdam Pharma Co N.V. growing faster?
NewAmsterdam Pharma Co N.V. is growing faster (55× against +2% a year earlier).
Which is more profitable, ADC Therapeutics SA or NewAmsterdam Pharma Co N.V.?
ADC Therapeutics SA is more profitable, with an operating margin of -132.0% against -230.6%.
More: ADC Therapeutics SA earnings · how ADC Therapeutics SA makes money · NewAmsterdam Pharma Co N.V. earnings · how NewAmsterdam Pharma Co N.V. makes money
From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Aug 13, 2026; 10-Q filed Nov 4, 2026). Fiscal quarters can end on different dates. Not investment advice.